XXXXXX- Xenon & Neural Inertia

Recruiting
99 years or below
All
Phase
N/A
20 participants needed
1 Location
Brief description of study
This pilot study involves the administration of xenon gas via the ENHANCER 3000 delivery system to 12 healthy adult volunteers; xenon concentrations will range from 0% to up to 75%. Subjects will wear an Actiwatch for 7 days and nights prior to xenon administration (Study Day) and 7 days/nights afterwards. Subjects will also undergo neurocognitive testing. They will undergo a series of head CTs before, during, and after xenon administration. The initial CT is a full-coverage CT, but subsequent scans will be limited to 3-slice acquisitions.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Neurocognitive Dysfunction
-
Age: 99 years or below
-
Gender: All
Updated on
19 Feb 2024.
Study ID: 824229